Cargando…
Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review
BACKGROUND: Immune checkpoint inhibitors (ICIs) have been proved having a better safety profile compared to platinum-based chemotherapy and have demonstrated encouraging anti-tumor therapeutic effects for patients with metastatic urothelial carcinoma (mUC). However, few studies have evaluated the ef...
Autores principales: | Ni, Kangxin, Yu, Chenhao, Wang, Huailan, Zhu, Shibin, Yu, Shicheng, Li, Gonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189380/ https://www.ncbi.nlm.nih.gov/pubmed/37206016 http://dx.doi.org/10.1016/j.heliyon.2023.e15813 |
Ejemplares similares
-
Camrelizumab monotherapy leading to partial remission for relapsed upper tract urothelial carcinoma after radical nephroureterectomy: a case report
por: Ni, Kangxin, et al.
Publicado: (2021) -
The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
por: Zhang, Zheng, et al.
Publicado: (2017) -
Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis
por: Yoshino, Takayuki, et al.
Publicado: (2023) -
Carrot intake and incidence of urothelial cancer: a systematic review and meta-analysis
por: Luo, Xiao, et al.
Publicado: (2017) -
Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma
por: Wu, Shuiqing, et al.
Publicado: (2017)